Snowball logo
logo
41L

Laboratorios Farmaceuticos Rovi S.A

€61.20€0.00  (0%)
Estimate
P/E
16.6
EPS
3.69
Beta
0.461
Growth
Revenue, YoY
20.02%
Net income, YoY
246.65%
FCF, YoY
1,831.36%
Dividends
Dividend yield
1.57%
Annual payout
€0.96
Next ex. div date
July 13, 27
Payout
34.06%
Div.growth, 5y
39.8%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
41L
ISIN
ES0157261019
Country
Other
Sector (GICS)
Other

Frequently asked questions

What sector does Laboratorios Farmaceuticos Rovi S.A (41L) operate in?

Laboratorios Farmaceuticos Rovi S.A belongs to the Other sector.

What is Laboratorios Farmaceuticos Rovi S.A (41L) current stock price?

As of the latest data, Laboratorios Farmaceuticos Rovi S.A stock price is €61.20, with a previous close of €61.20.

What is Laboratorios Farmaceuticos Rovi S.A (41L) Earnings Per Share (EPS)?

The trailing EPS is €3.69.

What is Laboratorios Farmaceuticos Rovi S.A (41L) Price-to-Earnings (P/E) ratio?

Laboratorios Farmaceuticos Rovi S.A current P/E ratio is 16.59.

What is Laboratorios Farmaceuticos Rovi S.A (41L) EBITDA?

Laboratorios Farmaceuticos Rovi S.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 101.06 million.

Does Laboratorios Farmaceuticos Rovi S.A (41L) pay dividends?

Yes. Laboratorios Farmaceuticos Rovi S.A pays annual dividends with an annualized yield of 1.57% and an estimated annual payout of €0.96 per share.

When is the next ex-dividend date for Laboratorios Farmaceuticos Rovi S.A (41L)?

The next ex-dividend date is scheduled for July 13, 2027.

When is Laboratorios Farmaceuticos Rovi S.A (41L) next earnings report?

Laboratorios Farmaceuticos Rovi S.A is expected to release its next earnings report on September 30, 2026.

What is Laboratorios Farmaceuticos Rovi S.A (41L) beta (volatility) score?

Laboratorios Farmaceuticos Rovi S.A has a beta of 0.461, indicating lower volatility than the overall market.